BIOBLAST-PHARMA.COM

Bioblast Pharma | Developing outstanding solutions for rare genetic diseases

Our Platforms and Pipeline. BioBlast is committed to transform excellent science into safe and effective therapies for rare genetic diseases. BioBlast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ – “ORPN”) committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company is led by a management team experienced in the development and commercialization of disease therapeutics. 2 Strict selection criteria. BioBlast Pharma...

http://www.bioblast-pharma.com/

OVERVIEW OF bioblast-pharma.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

0

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR BIOBLAST-PHARMA.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 14 reviews

5 star

6

4 star

4

3 star

2

2 star

0

1 star

2

Hey there! Start your review of bioblast-pharma.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

CONTACTS AT BIOBLAST-PHARMA.COM

BioBlast Pharma ltd

Dalia Meggido

Aha●●●aam

Tel●●●viv , 6520206

IL

972-●●●●6616

972-●●●●3340

ad●●●@topnotchcapital.com

View this contact

BioBlast Pharma ltd

Dalia Meggido

Aha●●●aam

Tel●●●viv , 6520206

IL

972-●●●●6616

972-●●●●3340

ad●●●@topnotchcapital.com

View this contact

BioBlast Pharma ltd

Dalia Meggido

Aha●●●aam

Tel●●●viv , 6520206

IL

972-●●●●6616

972-●●●●3340

ad●●●@topnotchcapital.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2013 May 09
UPDATED: 2014 April 09
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

12

YEARS
6

MONTHS
12

DAYS

NAME SERVERS

1: ns1.dtnt.info
2: ns2.dtnt.info
3: ns3.dtnt.info

REGISTRAR

DOMAIN THE NET TECHNOLOGIES LTD.

WHOIS : whois.domainthenet.com

REFERRED : http://www.domainthenet.com

CONTENT

PAGES IN
THIS WEBSITE

0

SSL

EXTERNAL LINKS

11

SITE IP

205.186.140.188

LOAD TIME

0 sec

SCORE

6.2

PAGE TITLE

Bioblast Pharma | Developing outstanding solutions for rare genetic diseases | bioblast-pharma.com Reviews

<META> DESCRIPTION

Our Platforms and Pipeline. BioBlast is committed to transform excellent science into safe and effective therapies for rare genetic diseases. BioBlast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ – “ORPN”) committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company is led by a management team experienced in the development and commercialization of disease therapeutics. 2 Strict selection criteria. BioBlast Pharma...

<META> KEYWORDS

1 about us

2 management

3 board of directors

4 platforms

5 product candidates

6 news

7 research

8 for patients

9 opmd

10 sbma soon

CONTENT

Page content here

KEYWORDS ON PAGE

about us,management,board of directors,platforms,product candidates,news,research,for patients,opmd,sbma soon,sma soon,friedrich’s ataxia soon,otcd soon,investors,search for,1 diversification,more news,enlarge image,investors lobby

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Bioblast Pharma | Developing outstanding solutions for rare genetic diseases | bioblast-pharma.com Reviews

https://bioblast-pharma.com

Our Platforms and Pipeline. BioBlast is committed to transform excellent science into safe and effective therapies for rare genetic diseases. BioBlast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ – “ORPN”) committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company is led by a management team experienced in the development and commercialization of disease therapeutics. 2 Strict selection criteria. BioBlast Pharma...

SUBDOMAINS

ir.bioblast-pharma.com

Investors Overview | Bioblast Pharma

Our Platforms and Pipeline. BioBlast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ - "ORPN") committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. Founded in 2012, the company is rapidly building a diverse portfolio of product candidates with the potential to address unmet medical need for incurable rare diseases. SCA3 POC - 2015 International Ataxia Research Conference. SMA-BBrm02 POC - CureSMA Meeting 2015. TEL AVIV, ...

LINKS TO THIS WEBSITE

curefa.org

FARA - Scientific Conferences

http://www.curefa.org/conference

Provided by OpenGlobal E-commerce. Please wait while your page loads . News and Press Releases. Clinical Network and Trials. For the Pharmaceutical Professionals. Autopsy and Tissue Donation. Message for New Families. Basics of Drug Development. Participation in Clinical Trials. Family Support and Resources. What is Friedreich's Ataxia? News and Press Releases. Clinical Network and Trials. For the Pharmaceutical Professionals. Autopsy and Tissue Donation. Message for New Families. Friedreich’s Ataxia Res...

friedreichsataxianews.com

BioBlast Presents Preclinical Proofs of Concept at Two Leading Scientific Meetings

http://friedreichsataxianews.com/2015/06/25/bioblast-presents-preclinical-proofs-concept-two-leading-scientific-meetings

This is a short description about myself and what this site is about. I hope you enjoy being here! BioBlast Presents Preclinical Proofs of Concept at Two Leading Scientific Meetings. June 25, 2015. July 2, 2015. Click here to receive Friedreich's Ataxia News via E-mail. The 19th International SMA Researcher Meeting. June 18-20, 2015 Westin Crown Center, Kansas City, Missouri, where BioBlast presented its proof of concept for BBrm02 (intrathecally-administered azithromycin). In a company press release o.

sma-daily.blogspot.com

SMA Daily: June 2015

http://sma-daily.blogspot.com/2015_06_01_archive.html

Spinal muscular atrophy - number one genetic killer in early infancy. Friday, June 26, 2015. BioBlast Pharma Announces Positive Preclinical for its Read-through Drug Candidate. A clinical-stage orphan disease-focused biotechnology company, announced positive preclinical in vitro and in vivo proof-of-concept study results for its Read-through drug candidate (BBrm02) for Spinal Muscular Atrophy. Spinal muscular atrophy cure. Spinal muscular atrophy research. Thursday, June 18, 2015. Wednesday, June 10, 2015.

sma-daily.blogspot.com

SMA Daily: BioBlast Pharma Announces Positive Preclinical for its Read-through Drug Candidate

http://sma-daily.blogspot.com/2015/06/bioblast-pharma-announces-positive.html

Spinal muscular atrophy - number one genetic killer in early infancy. Friday, June 26, 2015. BioBlast Pharma Announces Positive Preclinical for its Read-through Drug Candidate. A clinical-stage orphan disease-focused biotechnology company, announced positive preclinical in vitro and in vivo proof-of-concept study results for its Read-through drug candidate (BBrm02) for Spinal Muscular Atrophy. In a series of cell and mouse studies BBrm02 was effective in creating high levels of full length SMN2 protein.

UPGRADE TO PREMIUM TO VIEW 7 MORE

TOTAL LINKS TO THIS WEBSITE

11

OTHER SITES

bioblank.net

Index of /

Apache/2.4.29 (Unix) mod hive/6.6 OpenSSL/1.0.1e-fips mod fastcgi/2.4.6 Server at www.bioblank.net Port 80.

bioblas.com

Bioblas - Saç Dökülmesine Karşı Bitkisel Çözüm. Organic Oil, Procyanidin

Biota ailesinin üyesi Restorex - Biota59. SAÇ SORUNLARI VE ÇÖZÜMLERİ. SAÇ TİPİNİZE GÖRE ÇÖZÜMLER. Tüm saç problemleriniz için Bioblas Saç Uzmanı. Bioblas saç sağlığı ve saç dökülmesine karşı uzmanlığını, saç güzelliğine yönelik çözümler ile birleştirerek farklı ihtiyaçlara yönelik, iki ayrı seri ile karşınızda. Dökülmeyen, kökten uca güçlü saçlar. Saçları güçlendirerek, saç dökülmesini önler. Doğal ve organik içeriklerle saç tipine özel hassas ve yoğun bakım sağlar. SAÇ TİPİNİZE GÖRE ÇÖZÜMLER. Saç teller...

bioblaser.ch

Tausend und eine tomate: Hoffest am 13. Juli ab 16 Uhr und 14. Juli ab 13 Uhr 2013 · Infos hier klicken.

bioblask.pl

Kosmetyki naturalne - Bioblask.pl

Kosmetyki naturalne - naturalne piękno. Eubiona Aloe Vera Krem na dzień do cery normalnej i mieszanej. Eubiona Aloe Vera Krem na dzień. Krem o dużej zawartości wyciągu z bio aloesu. Poprawia elastyczność oraz wspomaga proces nawilżenia skóry. Ekstrakt z granatu wzmacnia i chroni skórę przed szkodliwym działaniem środowiska. Starannie dobrana kompozycja organicznych składników pielęgnuje cerę, czyniąc ją gładką i delikatną Pojemność 50ml. Eubiona Aloe Vera Krem na noc do cery normalnej i mieszanej. Krem p...

bioblast-blog.blogspot.com

Daniel D's BioBlog

Wednesday, June 1, 2011. Don't Judge a Book By Its Cover. Re these grotesque organisms the key to cure cancer? I believe they are. Some might say, “How in the world are these being going to help cure cancer? 8221; After my brief explanation, people reading this will understand that they have the potential to fight our dreaded foe. As you can see here, the naked mole rat has an advantage of detecting. I believe this is the cornerstone in finding a way not only to cure, but prevent cancer indefinitely....

bioblast-pharma.com

Bioblast Pharma | Developing outstanding solutions for rare genetic diseases

Our Platforms and Pipeline. BioBlast is committed to transform excellent science into safe and effective therapies for rare genetic diseases. BioBlast Pharma is a publicly traded, clinical-stage biotechnology company (NASDAQ – “ORPN”) committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases. The company is led by a management team experienced in the development and commercialization of disease therapeutics. 2 Strict selection criteria. BioBlast Pharma...

bioblast.at

Bioblast

Cookies help us deliver our services. By using our services, you agree to our use of cookies. 160; . 160; . 160; . 160; . 160; . 160; . 160; . 160; . 160; . 160; . 160; . 160; . For MitoPedia, MitoFit, and more. In the spirit of Gentle Science. You can click on this symbol in various pages to download a pdf file. Gentle Science discusses the concept of preprints. Mitochondrial respiratory states and rates: Building blocks of mitochondrial physiology. Picked up in the spirit of Gentle Science.

bioblast.dudnyk-clients.com

BioBlast Pharma Official Site | Home

Skip to main content. Thomas I. H. Dubin. Hope should not be rare. Find out how we are helping. To ensure hope is not rare. Learn how Bioblast Pharma is striving to meet the needs within the rare and ultra-rare disease community. Working toward a better tomorrow for patients with rare and ultra-rare genetic diseases. Bringing hope to patients. Learn about our lead product candidate trehalose 90 mg/mL IV solution. Supporting the rare disease community. Invest in innovation. Invest in Bioblast Pharma.

bioblast.info

Anfang - Hestia :: Kundendienst für Holzfeuerungen ::

Für wen sind wir da? Was wir für Sie tun. Sie brauchen einen professionellen. Partner für den Kundendienst an. Sehr gut - Sie haben ihn gefunden! Gen für die Zufriedenheit. HESTIA Service GmbH : Zillenberg : Kappelstraße 12 : 86510 Ried b Mering : Tel.: 08208 1264 :.

bioblast.net

Main Page - Bioblast.net

University course in Bioinformatics. Retrieved from " http:/ Bioblast.net/index.php/Main Page. Related Links [ Edit. This page was last modified on 25 May 2011, at 04:57. This page has been accessed 27,387 times. Content is available under BioLicense: the freest license.

bioblast.org

Main Page - Bioblast_org

BioBlast is the biological energy source. Bioblast is a synonym of mitochondrium. This page is about organizing information for biological energy metabolism and related genes and genomes. What is a bioblast? Retrieved from " http:/ Bioblast.org/index.php/Main Page. Related Links [ Edit. This page was last modified on 6 February 2010, at 12:50. This page has been accessed 45,155 times. Content is available under BioLicense: the freest license.